A Study of TNM001 in Chinese Healthy Preterm and Term Infants

NCT05630573 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: TNM001
BIOLOGICAL: Placebo

Sponsor

Zhuhai Trinomab Pharmaceutical Co., Ltd.